Answer
Pharmacokinetic interactions between dostarlimab and small-molecule medicines are not expected, although no interaction studies have been performed.
Sources for this answer
- JEMPERLI 500 mg concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.5 Interaction with other medicinal products · Version 14Document updated
Sources checked